LWAC
RETA

Laurel Wealth Advisors (California)’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History

Laurel Wealth Advisors (California)’s Portfolio RETA Stock Details RETA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-4,217
Closed -$424K – 788
2021
Q3 		$424K Buy
4,217
+250
+6% +$25.1K 0.08% 268
2021
Q2 		$561K Buy
3,967
+50
+1% +$7.07K 0.07% 258
2021
Q1 		$391K Buy
3,917
+1,475
+60% +$147K 0.06% 300
2020
Q4 		$302K Buy
+2,442
New +$302K 0.04% 331